U.S. CDC – Mozambique Evaluation

In Mozambique it is estimated that there are currently around 1.8 million people living with HIV . With a prevalence of about 15% in people aged 15 to 49, Mozambique is one of the countries most affected by HIV. Availability of oral fluid (OF) based rapid tests in Mozambique may permit expansion of testing while reducing the biohazard associated with finger prick or venous blood draw. We tested two colloidal gold immunochromatography rapid tests: OraQuick Advance®, and Chembio DPP®.

Download full study